These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34186273)

  • 1. Cardioneuroablation changes the type of vasovagal response in patients with asystolic reflex syncope.
    Piotrowski R; Żuk A; Baran J; Sikorska A; Kryński T; Kułakowski P
    Auton Neurosci; 2021 Nov; 235():102838. PubMed ID: 34186273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.
    Piotrowski R; Baran J; Sikorska A; Krynski T; Kulakowski P
    JACC Clin Electrophysiol; 2023 Jan; 9(1):85-95. PubMed ID: 36114133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation.
    Aksu T; Guler TE; Bozyel S; Yalin K; Gopinathannair R
    Europace; 2020 Sep; 22(9):1320-1327. PubMed ID: 32898255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B; Morillo CA; Sheldon RS; Chew DS; Aksu T; Raj SR
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.
    Tu B; Wu L; Hu F; Fan S; Liu S; Liu L; Ding L; Zheng L; Yao Y
    Heart Rhythm; 2022 Apr; 19(4):562-569. PubMed ID: 34896621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results.
    Pachon JC; Pachon EI; Cunha Pachon MZ; Lobo TJ; Pachon JC; Santillana TG
    Europace; 2011 Sep; 13(9):1231-42. PubMed ID: 21712276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right anterior ganglionated plexus: The primary target of cardioneuroablation?
    Hu F; Zheng L; Liang E; Ding L; Wu L; Chen G; Fan X; Yao Y
    Heart Rhythm; 2019 Oct; 16(10):1545-1551. PubMed ID: 31330187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasovagal syncope with asystole: the role of cardiac pacing.
    Brignole M; Tomaino M; Gargaro A
    Clin Auton Res; 2017 Aug; 27(4):245-251. PubMed ID: 28669088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study.
    Aksu T; Guler TE; Mutluer FO; Bozyel S; Golcuk SE; Yalin K
    J Interv Card Electrophysiol; 2019 Mar; 54(2):177-188. PubMed ID: 30054828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T; Chung MK
    Curr Cardiovasc Risk Rep; 2024 Apr; 18(4):55-64. PubMed ID: 38707611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study.
    Aksu T; Padmanabhan D; Shenthar J; Yalin K; Gautam S; Valappil SP; Banavalikar B; Guler TE; Bozyel S; Tanboga IH; Lakkireddy D; Olshansky RB; Gopinathannair R
    J Interv Card Electrophysiol; 2022 Jan; 63(1):77-86. PubMed ID: 33527216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioneuroablation for vasovagal syncope: insights on patients' selection, centre settings, procedural workflow and endpoints-results from an European Heart Rhythm Association survey.
    Penela D; Berruezo A; Roten L; Futyma P; Richter S; Falasconi G; Providencia R; Chun J
    Europace; 2024 May; 26(5):. PubMed ID: 38781099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials.
    Chakraborty P; Chen PS; Gollob MH; Olshansky B; Po SS
    Heart Rhythm; 2024 Apr; 21(4):464-470. PubMed ID: 38104955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Age on Magnitude and Timing of Vasodepression and Cardioinhibition in Tilt-Induced Vasovagal Syncope.
    van Dijk JG; van Rossum IA; van Houwelingen M; Ghariq M; Saal DP; de Lange FJ; Thijs RD; Sutton R; Benditt DG
    JACC Clin Electrophysiol; 2022 Aug; 8(8):997-1009. PubMed ID: 35981805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3).
    Brignole M; Donateo P; Tomaino M; Massa R; Iori M; Beiras X; Moya A; Kus T; Deharo JC; Giuli S; Gentili A; Sutton R;
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):10-6. PubMed ID: 24336948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective vagal innervation principles of ganglionated plexi: step-by-step cardioneuroablation in a patient with vasovagal syncope.
    Aksu T; Guler TE; Bozyel S; Yalin K
    J Interv Card Electrophysiol; 2021 Apr; 60(3):453-458. PubMed ID: 32394104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioneuroablation for cardioinhibitory vasovagal syncope.
    John LA; Mullis A; Payne J; Tung R; Aksu T; Winterfield JR
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1748-1753. PubMed ID: 33855779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioneuroablation for severe neurocardiogenic syncope.
    Santos Silva G; Fonseca P; Cardoso F; Almeida J; Ribeiro S; Oliveira M; Sanfins V; Gonçalves H; Pachon M JC; Barra S; Primo J; Lourenço A; Fontes-Carvalho R
    Rev Port Cardiol; 2023 Oct; 42(10):821-829. PubMed ID: 37268266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.